Trending Topic

3D rendered Medical Illustration of Male Anatomy - Rectal Cancer.
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriel Valagni, Nkafu Bechem Ndemazie, Tiago Biachi de Castria

Trifluridine/tipiracil (FTD/TPI) is a novel oral formulation of two drugs with promising results in the treatment of metastatic colorectal cancer (mCRC).1 Trifluridine is a thymidine-based nucleoside analogue that, after intracellular phosphorylation, gets incorporated into DNA, causing DNA dysfunction.2 It was first identified by Callahan et al. in 1996 as an active impurity in the herbicide trifluralin, which […]

Daniel Kelly, ESMO 2018 – The European Oncology Nurses Society’s RECaN Project

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 2nd 2018

The European Oncology Nurses Society (EONS) is currently undertaking its RECaN project which is aimed at increasing the recognition of cancer nursing across Europe. At this year’s ESMO congress, EONS presented the first two phases of the RECaN project. Past President of EONS, Prof Daniel Kelly, is passionate about this project and what it can bring to the field of cancer nursing. We caught up with Prof Kelly, at ESMO 2018 to discuss the RECaN project and the work of EONS. He emphasised the importance of EONS’ network of support, and how they encourage development in cancer nursing by offering education programmes, fellowships, travel scholarships, and more.

Questions:
1. In your time as president of the European Oncology Nurses Society (EONS), of what achievement are you most proud? (0:11)
2. What are the most important educational needs of cancer nurses? (0:38)
3. What can EONS offer to young cancer nurses embarking on a career? (0:59)
4. As well as educational support, what other resources does EONS offer to cancer nurses? (1:27)
5. Which presentations at ESMO will most help the aims of EONS? (1:57)

Speaker disclosures: Daniel Kelly has nothing to disclose in relation to this interview.

Filmed at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, 19–23 October 2018

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup